{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:53:47Z","timestamp":1763348027428},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/01.jaa.0000476217.57808.c4","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T01:57:40Z","timestamp":1454119060000},"page":"1-4","source":"Crossref","is-referenced-by-count":5,"title":["Botulinum toxin as a treatment for refractory overactive bladder"],"prefix":"10.1097","volume":"29","author":[{"given":"Shatril","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Rizzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11934-014-0438-x","article-title":"Management of refractory OAB in the non-neurogenic patient.","volume":"15","author":"Wadie","year":"2014","journal-title":"Curr Urol Rep"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2296-10-8","article-title":"Prevalence, evaluation and management of overactive bladder in primary care.","volume":"10","author":"Cheung","year":"2009","journal-title":"BMC Fam Pract"},{"key":"R5-14-20210130","first-page":"1","article-title":"Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life.","volume":"6","author":"Jayarajan","year":"2013","journal-title":"Res Rep Urol"},{"issue":"3","key":"R6-14-20210130","first-page":"935","article-title":"Mirabegron for overactive bladder: a novel, first-in-class 3-agonist therapy.","volume":"10","author":"Imran","year":"2013","journal-title":"Urol J"},{"issue":"5","key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11934-012-0274-9","article-title":"Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.","volume":"13","author":"Staskin","year":"2012","journal-title":"Curr Urol Rep"},{"issue":"3","key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1442-2042.2011.02946.x","article-title":"Botulinum toxin type A for the treatment of lower urinary tract disorders.","volume":"19","author":"Yokoyama","year":"2012","journal-title":"Int J Urol"},{"issue":"suppl 1","key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2008.07822.x","article-title":"Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity.","volume":"102","author":"Drake","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"Onabotulinumtoxin A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J.","volume":"189","author":"Nitti","year":"2013","journal-title":"Urol"},{"issue":"2","key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"Onabotulinumtoxin A 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0974-7796.82170","article-title":"Prospective randomized trial of 100u vs 200u Botox in the treatment of idiopathic overactive bladder.","volume":"3","author":"Altaweel","year":"2011","journal-title":"Urol Ann"},{"issue":"4","key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.juro.2008.11.110","article-title":"What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.","volume":"181","author":"Khan","year":"2009","journal-title":"J Urol"},{"issue":"1","key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","article-title":"Refractory idiopathic urge urinary incontinence and botulinum A injection.","volume":"180","author":"Brubaker","year":"2008","journal-title":"J Urol"},{"issue":"6","key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxin A for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial.","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"issue":"3","key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","article-title":"Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.","volume":"28","author":"Cohen","year":"2009","journal-title":"Neurourol Urodyn"}],"container-title":["Journal of the American Academy of Physician Assistants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000476217.57808.c4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:45:36Z","timestamp":1620931536000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01720610-201602000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000476217.57808.c4","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}